Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Maternal serum protein profile and immune response protein subunits as markers for non‐invasive prenatal diagnosis of trisomy 21, 18, and 13

1 Feb 2013

Abstract excerpt

OBJECTIVES: To use proteomics to identify and characterize proteins in maternal serum from patients at high-risk for fetal trisomy 21, trisomy 18, and trisomy 13 on the basis of ultrasound and maternal serum triple tests. METHODS: We performed a comprehensive proteomic analysis on 23 trisomy cases and 85 normal cases during the early second trimester of pregnancy. Protein profiling along with conventional sodium...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gestational Trophoblastic Disease Studies
Share to Neonatal and Maternal Infections
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23371439
DOI: 10.1002/pd.4047

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Maternal serum protein profile and immune response protein subunits as markers for non‐invasive prenatal diagnosis of trisomy 21, 18, and 13PMID 23371439Read ↗

Proteomic profile determination of autosomal aneuploidies by mass spectrometry on amniotic fluidsSemantic proximity Read ↗

Multiplexed Quantification of First-Trimester Serum Biomarkers in Healthy PregnancySemantic proximity Read ↗

First trimester screening for other trisomies than trisomy 21, 18, and 13Semantic proximity Read ↗

Maternal serum pregnancy‐associated plasma protein a and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancySemantic proximity Read ↗

Human coelomic fluid investigation: A MS-based analytical approach to prenatal screeningSemantic proximity Read ↗

Comprehensive maternal serum proteomics identifies the cytoskeletal proteins as non-invasive biomarkers in prenatal diagnosis of congenital heart defectsSemantic proximity Read ↗

Proteomic Analysis of Maternal Serum in Down Syndrome: Identification of Novel Protein BiomarkersSemantic proximity Read ↗

Comprehensive Proteomic Analysis of the Human Amniotic Fluid Proteome: Gestational Age-Dependent ChangesSemantic proximity Read ↗

First trimester maternal serum pregnancy‐associated plasma protein A and pregnancy‐specific βl‐glycoprotein in fetal trisomiesSemantic proximity Read ↗

Biology of pregnancy‐associated plasma protein‐A in relation to prenatal diagnostics: an overviewSemantic proximity Read ↗

Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasmaSemantic proximity Read ↗

Gravida Serum POSTN and PAPPA as the Potential Biomarkers for Fetal Congenital Heart Disease Based on Quantitative and Qualitative ProteomicsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.